Results 81 to 90 of about 978,166 (202)

Treatment Approaches for Diffuse Cutaneous Mastocytosis in Children: Literature Review and Actual Clinical Experience

open access: yesВопросы современной педиатрии
Background. Mastocytosis is a very rare disease with various manifestations, based on abnormal clonal proliferation of mast cells in organs and tissues, such as: skin, bone marrow, lymph nodes, liver, spleen, and gastrointestinal tract. The diagnosis can
Timur T. Valiev   +6 more
doaj   +1 more source

Two patients with osteoporosis:initial presentation of systemic mastocytosis

open access: yes, 2008
In two patients with osteoporosis, systemic mastocytosis ultimately turned out to be the underlying disease. Both patients had a history of anaphylactic reactions caused by wasp stings but did not have any skin or other symptoms.
Verhage, Albert H.   +3 more
core   +1 more source

Indolent systemic mastocytosis: a case and review of the current available treatment options [PDF]

open access: yes, 2013
Mastocytosis denotes a heterogeneous group of disorders characterized by abnormal growth and accumulation of mast cells. Cutaneous mastocytosis is characterized by skin-limited disease and is the most common subtype.
Lee, Yvonne   +7 more
core   +1 more source

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia

open access: yesCase Reports in Medicine, 2014
Mastocytosis is a myeloproliferative neoplasm characterized by clonal expansion of abnormal mast cells, ranging from the cutaneous forms of the disease to mast cell leukemia.
Theodoros Iliakis   +13 more
doaj   +1 more source

Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy

open access: yesHaematologica, 2014
Chronic myeloid leukemia and systemic mastocytosis are myeloid neoplasms sharing a number of pathogenetic and clinical features. In both conditions, an aberrantly activated oncoprotein with tyrosine kinase activity, namely BCR-ABL1 in chronic myeloid ...
Siham Bibi   +9 more
doaj   +1 more source

Systemic Mastocytosis with associated CMML

open access: yes, 2018
Systemic mastocytosis refers to a heterogeneous group of clinical disorders characterized by excessive mast cell accumulation in one or multiple organs.
Tawadros, Fady, Chakraborty, Kanishka
core   +1 more source

Mast Cell Leukemia: Review of a Rare Disease and Case Report of Prolonged Survival after Allogeneic Stem Cell Transplant

open access: yesHuman Pathology: Case Reports, 2017
Mast cell leukemia is a rare and aggressive form of mastocytosis characterized by >20% mast cells found in the bone marrow aspirates of patients with signs of systemic mastocytosis-related organ damage.
James Bauer, MD, PhD   +2 more
doaj   +1 more source

Systemic Mastocytosis: A Rare Cause of Diarrhea

open access: yes, 2020
Mastocytosis is a spectrum of neoplastic, clonal cell disorders that are characterized by mast cell hyperplasia and accumulation. Disease and clinical presentation can vary depending on the extent of spread, ranging from skin-limited cutaneous ...
Hamera, Leonard, MD   +4 more
core   +1 more source

Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case

open access: yesCase Reports in Oncological Medicine, 2016
Systemic mastocytosis (SM) is a disease characterized by a clonal infiltration of mast cells affecting various tissues of the body. It is grouped into six different subtypes according to the World Health Organization classification. It is called indolent
Sassine Ghanem   +4 more
doaj   +1 more source

Role of Cysteinyl Leukotrienes in Food Allergy and Anaphylaxis: A Potential Therapeutic Target

open access: yes
Allergy, Volume 81, Issue 10, Page 3763-3765, October 2026.
Adrienn Weingärtner, Thomas Eiwegger
wiley   +1 more source

Home - About - Disclaimer - Privacy